Industry Programs Director Karen Conway will deliver keynote address at Biotech Supply Chain Academy Conference on Oct. 26
LOUISVILLE, Colo., Oct. 25 /PRNewswire/ -- With one of the most important pieces of healthcare legislation since Medicare now law, members of the healthcare supply chain continue to assess how their organizations will be affected and how they can derive value from the changes that are occurring. Karen Conway, Industry Programs director for GHX, will explore some of the avenues for consideration in a keynote address to the Biotech Supply Chain Academy Conference on Oct. 26 in San Francisco.
As an industry thought leader and with more than a decade of expertise in healthcare supply chain optimization, Conway will offer insights into the Patient Protection and Affordable Care Act of 2010, as amended by the Health Care and Education Reconciliation Act of 2010—commonly known as the healthcare reform bill. The bill, whose provisions take effect over a period of several years, will have an impact on nearly every aspect of the U.S. healthcare delivery system, and healthcare supply chain executives will have to work quickly to respond to the challenges of new taxes, new regulations and new administrative deadlines.
In her address, Conway will explore how healthcare providers, payers, retailers, distributors and life sciences representatives can position their organizations for the post-reform world. Her presentation, entitled "Healthcare: Prospering in a Post-reform World," will address which provisions of the law have implications for the supply chain and will provide a blueprint for how the supply chain can contribute to both better quality of patient care and lower healthcare costs.
For information about the conference, go to: http://www.biosupplyalliance.org/supplychainacademy.html.
About GHX
As the business hub for healthcare, Global Healthcare Exchange, LLC (GHX) enables healthcare providers and suppliers in North America and Europe to reduce costs and improve margins by automating processes, reducing operating expenses and increasing knowledge-based decision making. Products and services include trading partner connectivity, order and contract management and validation, data synchronization, sales force automation and business intelligence. Equity owners of GHX are Abbott Exchange, Inc.; AmerisourceBergen Corp.; Baxter Healthcare Corp.; B. Braun Medical Inc.; BD; Boston Scientific Corp.; Cardinal Health, Inc.; Covidien; C.R. Bard, Inc.; Thermo Fisher Scientific Inc.; GE Healthcare; HCA; Johnson & Johnson Health Care Systems Inc.; McKesson Corp.; Medtronic USA, Inc.; Owens & Minor; Premier, Inc.; Siemens; University HealthSystem Consortium; and VHA Inc. For more information, visit www.ghx.com.
SOURCE GHX